Results for tag: "Antiarrhythmic"

The antiarrhythmic market is a subset of the cardiovascular drug market, which includes drugs used to treat abnormal heart rhythms. Antiarrhythmic drugs are used to treat arrhythmias, which are abnormal heart rhythms that can cause symptoms such as palpitations, dizziness, and chest pain. These drugs work by blocking or slowing down electrical signals in the heart, restoring the normal rhythm. Common types of antiarrhythmic drugs include beta blockers, calcium channel blockers, and potassium channel blockers. The antiarrhythmic market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, Sanofi, Novartis, and GlaxoSmithKline. Other companies in the market include Bristol-Myers Squibb, AstraZeneca, and Boehringer Ingelheim. Show Less Read more